Abstract P5-15-06: Potential Medicare beneficiary out-of-pocket cost reductions through use of biosimilar filgrastim-sndz over reference filgrastim among breast cancer patients: A simulation model analysis

Mapping Intimacies ◽

10.1158/1538-7445.sabcs18-p5-15-06 ◽

2019 ◽

Author(s):

G Puckrein ◽

L Xu ◽

A Ryan ◽

K Campbell ◽

S Balu

Keyword(s):

Breast Cancer ◽

Simulation Model ◽

Cancer Patients ◽

Medicare Beneficiary ◽

Model Analysis ◽

Breast Cancer Patients ◽

Cost Reductions ◽

Biosimilar Filgrastim

Download Full-text

Parameterization of a disease progression simulation model for sequentially treated metastatic human epidermal growth factor receptor 2 positive breast cancer patients

Current Medical Research and Opinion ◽

10.1185/03007995.2016.1149056 ◽

2016 ◽

Vol 32 (6) ◽

pp. 991-996 ◽

Cited By ~ 6

Author(s):

Vakaramoko Diaby ◽

Askal A. Ali ◽

Georges Adunlin ◽

Christine G. Kohn ◽

Alberto J. Montero

Keyword(s):

Breast Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Simulation Model ◽

Cancer Patients ◽

Growth Factor Receptor ◽

Breast Cancer Patients ◽

Epidermal Growth ◽

Positive Breast Cancer

Download Full-text

PARAMETERIZATION OF A DISEASE PROGRESSION SIMULATION MODEL FOR SEQUENTIALLY TREATED METASTATIC HER2-POSITIVE BREAST CANCER PATIENTS

Value in Health ◽

10.1016/j.jval.2016.03.1810 ◽

2016 ◽

Vol 19 (3) ◽

pp. A88

Author(s):

A.A. Ali ◽

V. Diaby ◽

G. Adunlin ◽

C.G. Kohn ◽

A.J. Montero

Keyword(s):

Breast Cancer ◽

Simulation Model ◽

Disease Progression ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Comparison of effectiveness of biosimilar filgrastim (Nivestim™), reference Amgen filgrastim and pegfilgrastim in febrile neutropenia primary prevention in breast cancer patients treated with neo(adjuvant) TAC: a non-interventional cohort study

Supportive Care in Cancer ◽

10.1007/s00520-015-2818-2 ◽

2015 ◽

Vol 24 (2) ◽

pp. 597-603 ◽

Cited By ~ 9

Author(s):

M. Brito ◽

S. Esteves ◽

R. André ◽

M. Isidoro ◽

A. Moreira

Keyword(s):

Breast Cancer ◽

Cohort Study ◽

Primary Prevention ◽

Febrile Neutropenia ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Comparison Of Effectiveness ◽

Biosimilar Filgrastim

Download Full-text

CP-169 Effectiveness of biosimilar filgrastim vs original granulocyte-colony stimulating factor (G-CSF) in febrile neutropenia prevention in breast cancer patients receiving docetaxel/doxorubicin/cyclophosphamide (TAC)

European Journal of Hospital Pharmacy ◽

10.1136/ejhpharm-2016-000875.169 ◽

2016 ◽

Vol 23 (Suppl 1) ◽

pp. A75.1-A75 ◽

Cited By ~ 3

Author(s):

I Puértolas Tena ◽

MA Alcácera López ◽

M Merchante Andreu ◽

E Fernández Alonso ◽

M Gimeno Gracia ◽

...

Keyword(s):

Breast Cancer ◽

Febrile Neutropenia ◽

Cancer Patients ◽

Granulocyte Colony Stimulating Factor ◽

Colony Stimulating Factor ◽

Breast Cancer Patients ◽

Stimulating Factor ◽

Biosimilar Filgrastim ◽

Factor G

Download Full-text

Effectiveness of biosimilar filgrastim vs. original granulocyte colony-stimulating factors in febrile neutropenia prevention in breast cancer patients

European Journal of Clinical Pharmacology ◽

10.1007/s00228-017-2365-5 ◽

2017 ◽

Vol 74 (3) ◽

pp. 315-321 ◽

Cited By ~ 4

Author(s):

Isabel Puértolas ◽

Alberto Frutos Pérez-Surio ◽

María Aránzazu Alcácera ◽

Raquel Andrés ◽

María del Tránsito Salvador

Keyword(s):

Breast Cancer ◽

Febrile Neutropenia ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Colony Stimulating Factors ◽

Biosimilar Filgrastim

Download Full-text

Bisphosphonates in Breast Cancer Patients with Skeletal Metastases

Hematology/Oncology Clinics of North America ◽

10.1016/s0889-8588(18)30193-x ◽

1994 ◽

Vol 8 (1) ◽

pp. 153-163 ◽

Cited By ~ 6

Author(s):

Charles L. Shapiro

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Skeletal Metastases ◽

Breast Cancer Patients

Download Full-text

Does ultrasonographic examination of the axilia in the preoperative screening of breast cancer patients reduce the number of sentinel lymph node procedures?

European Journal of Cancer ◽

10.1016/s0959-8049(02)80162-9 ◽

2002 ◽

Vol 38 (11) ◽

pp. S58 ◽

Cited By ~ 2

Author(s):

E Deurloo

Keyword(s):

Breast Cancer ◽

Lymph Node ◽

Sentinel Lymph Node ◽

Cancer Patients ◽

Preoperative Screening ◽

Breast Cancer Patients ◽

Ultrasonographic Examination

Download Full-text

Steroid receptors and insulin-like growth factor expression in the endometrium of breast cancer patients on tamoxifen compared with controls

European Journal of Cancer ◽

10.1016/s0959-8049(02)80435-x ◽

2002 ◽

Vol 38 (11) ◽

pp. S133

Author(s):

Z Rayter

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Cancer Patients ◽

Steroid Receptors ◽

Insulin Like Growth Factor ◽

Breast Cancer Patients ◽

Factor Expression ◽

Growth Factor Expression

Download Full-text

PAI-1 is independent prognostic factor in the elderly breast cancer patients

European Journal of Cancer ◽

10.1016/s0959-8049(02)80358-6 ◽

2002 ◽

Vol 38 (11) ◽

pp. S111

Author(s):

B Pajk

Keyword(s):

Breast Cancer ◽

Prognostic Factor ◽

Cancer Patients ◽

The Elderly ◽

Independent Prognostic Factor ◽

Breast Cancer Patients ◽

Pai 1

Download Full-text

Gemcitabine in metastatic breast cancer patients previously treated with anthracyclines and taxanes. Evaluation of response toxicity

European Journal of Cancer ◽

10.1016/s0959-8049(02)80224-6 ◽

2002 ◽

Vol 38 (11) ◽

pp. S74 ◽

Cited By ~ 2

Author(s):

G Lerzo

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Previously Treated

Download Full-text